DYN
Dyne Therapeutics, Inc. · Healthcare
Director Jason P Rhodes sold $1.9M of Dyne Therapeutics, Inc.
Sold$1,936,341
$18.14Price
106,723Shares
−9%Stake
What DYN did after the filing
- The stock from Thu, May 7 open, $18.85
- +10.7%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Jun 22 close.
Traded Mon, May 4. Filed Wed, May 6, 5:09 PM ET, after the close. Returns use the May 7 open and the Jun 22 close. Not investment advice.